arginine has been researched along with Adenocarcinoma in 123 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (25.20) | 18.7374 |
1990's | 48 (39.02) | 18.2507 |
2000's | 25 (20.33) | 29.6817 |
2010's | 14 (11.38) | 24.3611 |
2020's | 5 (4.07) | 2.80 |
Authors | Studies |
---|---|
Guo, QX; Li, M; Liu, Y; Long, WB; Pu, X; She, Q; Tang, Y; Wang, YL | 1 |
Zaki Mahdi, N | 1 |
Gluhacevic von Krüchten, L; Keller, M; Maschauer, S; Prante, O; Schindler, L; Wohlfahrt, K | 1 |
Nahhas, AF; Webster, TJ | 1 |
Chen, F; Guo, Q; Huang, Z; Lin, J; Liu, H; Xu, J; Yao, Q; Zhang, Z | 1 |
Gamberini, L; Laici, C; Loforte, A; Ravaioli, M; Siniscalchi, A | 1 |
Chen, J; Chen, Y; Ji, J; Li, X; Li, Y; Ma, C; Song, Y; Sun, Q; Wang, S; Wu, H | 1 |
Cheng, PN; Ho, JC; Lam, SK; Li, YY; U, KP; Xu, S | 1 |
Bala, A; Panditharadyula, SS | 1 |
Attili, VS; Jamil, K; Madireddy, UR; Natukula, K; Pingali, UR | 1 |
Bergman Laurila, J; Grafström, R; Hammerling, U; Ilbäck, NG | 1 |
Lee, RJ; Li, Y; Teng, L; Wang, X | 1 |
Chen, H; Gupta, V; Lorton, B; Shechter, D | 1 |
Agle, S; Hayat, T; Martin, RC; McMasters, KM; Philips, P; Schlegel, M; Scoggins, CR | 1 |
Büssemaker, E; Hagedorn, C; Hausberg, M; Hillebrand, U; Kliche, K; Lang, D; Oberleithner, H; Pavenstädt, H; Reuter, S; Stock, CM; Telgmann, RG | 1 |
Asomaning, K; Bradbury, PA; Cescon, DW; Christiani, DC; Heist, RS; Hopkins, J; Kulke, M; Liu, G; Lynch, TJ; Ma, C; Marshall, AL; Su, L; Wain, JC; Wang, Z; Xu, W; Zhai, R; Zhou, W | 1 |
Donglan, S; Na, W; Rongmiao, Z; Yan, L; Yanan, D; Zhifeng, C | 1 |
Jin, H; Li, A; Liu, D; Liu, H; Wang, B; Wang, D; Zhang, D | 1 |
Bellone, M; Capuano, G; Freschi, M; Generoso, L; Grioni, M; Jachetti, E; Ricupito, A; Rigamonti, N | 1 |
Pi, M; Quarles, LD | 1 |
Morehouse, TJ; Thomas, LN; Too, CK | 1 |
Fidler, C; Pilozzi, E; Platt, A; Ruco, L; Talerico, C | 1 |
Alderson, D; Farthing, MJ; Feakins, R; Hollowood, A; Holly, J; Moorghen, M; Newcomb, P; Storey, A; Zhang, ZW | 1 |
BLACKWOOD, CE; LONG, ME; MANDL, I | 1 |
Alderson, D; Farthing, MJ; Feakins, R; Gupta, J; Hollowood, A; Holly, J; Laurence, NJ; Moorghen, M; Newcomb, P; Zhang, ZW | 1 |
Cabrera, W; Dragani, TA; Falvella, FS; Galbiati, F; Galvan, A; Ibanez, O; Mancuso, MT; Manenti, G; Pazzaglia, S; Pignatiello, C; Saran, A; Spinola, M; Zaffaroni, D | 1 |
Bussolati, O; Dall'Asta, V; Gazzola, GC; Rotoli, BM; Sala, R | 1 |
Battistini, L; Borsellino, G; Bronte, V; Gallana, K; Gri, G; Iafrate, M; Kasic, T; Marigo, I; Pagano, F; Prayer-Galetti, T; Viola, A | 1 |
Bencko, V; Boffetta, P; Borel, S; Brennan, P; Canzian, F; Chabrier, A; Fabianova, E; Foretova, L; Hall, J; Hung, RJ; Janout, V; Lissowska, J; Mates, D; Rudnai, P; Szeszenia-Dabrowska, N; Zaridze, D | 1 |
Guo, L; Li, J; Ma, Y; Vogel, U; Wang, H; Yin, J | 1 |
Coëffier, M; Déchelotte, P; Ducrotté, P; Gargala, G; Lemoulan, S; Marion, R | 1 |
Beloussow, K; Shen, LJ; Shen, WC | 1 |
Borg, A; Dziadziuszko, R; Jassem, E; Jassem, J; Kobierska-Gulida, G; Limon, J; Rzyman, W; Szymanowska, A | 1 |
Bartsch, H; Butkiewicz, D; Dienemann, H; Edler, L; Muley, T; Popanda, O; Risch, A; Schattenberg, T; Schmezer, P; Waas, P | 1 |
Bearzi, I; Belvederesi, L; Bianchi, F; Bracci, R; Catalani, R; Cellerino, R; Galizia, E; Loretelli, C; Porfiri, E; Turchi, C; Viel, A | 1 |
Benais-Pont, G; Buchegger, F; Dupertuis, YM; Pichard, C | 1 |
Kim, DH; Kim, JH; Kim, KW; Min, BH; Yu, YS | 1 |
Deppert, W; Heinlein, C; Krepulat, F; Löhler, J; Speidel, D; Tolstonog, GV | 1 |
Gao, X; Ma, Q; Ma, Z; Song, Z; Wang, Y | 1 |
Ambrogio, C; Gasic, G; Karpatkin, S; Pearlstein, E | 2 |
Ip, C; Kim, U; Pine, MJ | 1 |
Pawlicka, E; Pałka, JA | 1 |
Bhide, SV; Maru, GB; Sawai, MM | 1 |
Chénais, B; Lepoivre, M; Tenu, JP; Yapo, A | 2 |
Drapier, JC; Hirling, H; Kaldy, P; Kühn, LC; Wietzerbin, J | 2 |
Baylis, SA; Charles, IG; Jenkins, DC; Lelchuk, R; Moncada, S; Radomski, MW | 1 |
Bonaventura, J; DeAngelo, J; Dewhirst, MW; Dodge, RK; Meyer, RE; Ong, ET; Shan, S | 1 |
Blachier, F; Duée, PH; M'Rabet-Touil, H; Robert, V; Selamnia, M | 1 |
Cendan, JC; Copeland, EM; Lind, DS; Souba, WW | 2 |
Bakker, A; Finkelstein, SD; Keller, G; Pricolo, VE; Przygodzki, R; Sayegh, R; Swalsky, PA | 1 |
Curley, SA; Feig, B; Kleinerman, ES; Klostergaard, J; Oyedeji, C; Roh, MS | 1 |
Chi, CW; Chiu, CC; Liu, WY; P'eng, FK; Wang, SR; Wu, CW; Wu, HS | 1 |
Baguley, BC; Li, Z; Thomsen, LL; Veszelovszky, E | 1 |
Lala, PK; Orucevic, A | 2 |
Billiar, TR; Geller, DA; Hatakeyama, K; Liu, ZZ; Morris, SM; Nussler, AK | 1 |
Chadee, K; Göttke, M | 1 |
Buckley, BJ; Dewhirst, MW; Hughes, CS; Lindberg, RA; Whorton, AR | 1 |
Furfine, ES; Garvey, EP; Sherman, PA | 1 |
Corbella, J; Estape, J; Firvida, J; Fuentes, M; Galan, C; Gene, M; Gomez-Catalan, J; Huguet, E; Rodamilans, M; To-Figueras, J | 1 |
Frend, AJ; Keerie, AJ; Knowles, RG; Scott, JM; Thomsen, LL; Topley, P | 1 |
Ah-See, AK; Dewar, J; Eremin, O; Heys, SD; Hutcheon, AW; Miller, I; Ogston, K; Sarker, TK; Walker, LG | 1 |
Fujisawa, T; Kakisawa, K; Kimura, H; Murata, M; Shirasawa, H; Tagawa, M | 1 |
Ma, Q; O'rourke, D; Rowlands, BJ; Williamson, KE | 1 |
Csiba, A; Hullán, L; Szarvas, T; Szende, B; Trézl, L | 1 |
Baber, GB; Boyd, JC; Malcolm, EK; Stoler, MH | 1 |
Cox, HM; Holliday, ND; Tough, IR; Zandvliet, DW | 1 |
Chang, CI; Kuo, L; Liao, JC | 1 |
Downes, CP; Hill, E; Smythe, E; van Der Kaay, J | 1 |
Christiani, DC; Fan, R; Liu, G; Lynch, TJ; Miller, DP; Su, L; Thurston, SW; Wain, JC; Xu, LL; Zhou, W | 1 |
Lucas, WE; Yen, SS | 1 |
Kitamura, M; Taga, S; Takeda, Y; Tei, N; Tominaga, T | 1 |
Cowden, RR; Harrison, FW; Zambernard, J | 1 |
Andrade, SP; Hart, IR; Piper, PJ | 1 |
Flaman, JM; Henry, Y; Lepoivre, M | 1 |
Hitch, DC; Kubota, A; Meguid, MM | 1 |
Holmes, L; Jenkins, DC; Moncada, S; Radomski, MW | 1 |
Brunson, ME; Risley, GL; Yeatman, TJ | 1 |
Klostergaard, J; Lopez-Berestein, G; Sivaramakrishnan, MR; Tucker, SD | 1 |
Amber, IJ; Hibbs, JB; Johnson, BB; Parker, CJ; Taintor, RR; Vavrin, Z | 1 |
Bajorunas, D; Brennan, MF; Cersosimo, E; McDermott, K; Pesola, G; Pisters, PW | 1 |
Chenais, B; Lemaire, G; Lepoivre, M; Tenu, JP; Thelander, L; Yapo, A | 1 |
Lepoivre, M; Petit, JF; Schott, C; Stoclet, JC | 1 |
Bandy, MD; Eto, I | 1 |
Ahrén, B; Bengmark, S; Sjövall, S | 1 |
Boudbid, H; Lepoivre, M; Petit, JF | 1 |
Cattran, DC; Chow, S; Roscoe, J | 1 |
Amber, IJ; Hibbs, JB; Taintor, RR; Vavrin, Z | 1 |
Arione, R; Benetton, G; Cornaglia-Ferraris, P; Forni, G; Giovarelli, M; Jemma, C; Musso, T | 1 |
Baba, H; Demura, H; Demura, R; Miura, K; Nunokawa, T | 1 |
Landon, J; Ratcliffe, JG; Rees, LH; Scott, AP | 1 |
Good, RA; Jose, DG | 1 |
Aoki, TT; Brennan, MF; Muller, WA; Tan, MH | 1 |
Kellen, JA; Lustig, V | 1 |
Kasten, FH; Strasser, FF | 1 |
Chai, H; Li, X; Liu, M; Tang, H; Tian, R | 1 |
Lieber, MM | 1 |
Calciati, A; Conte, PF; Giaccone, G; Musella, R | 1 |
Lum, BL; Torti, FM | 1 |
Alberts, DS; Dorr, RT | 1 |
Brattain, MG; Long, BH; Musial, ST | 3 |
Kang, S; Li, J; Li, L | 1 |
Desjardins, LM; MacManus, JP | 1 |
Gemba, K; Kiura, K; Matsumura, T; Moritaka, T; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Takigawa, N; Ueoka, H | 1 |
Hidaka, K; Hirohashi, Y; Hisatsugu, T; Kohno, K; Kuwano, M; Sato, S | 1 |
Berti, E; Berti, T; Carrara, M; D'Ancona, S; Ragazzi, E | 1 |
Baker, LH; Fraile, RJ; Samson, MK; Talley, RW | 1 |
Sano, K; Shitara, N; Takakura, K; Yamamoto, H | 1 |
Baker, LH; Fraile, RJ; Hire, EA; Samson, MK | 1 |
Caramia, G; Messana, V; Pavone-Macaluso, M; Rizzo, FP | 1 |
Beck, H; Capranico, G; Gazdar, AF; Giaccone, G; Zunino, F | 1 |
Lorico, A; Rappa, G; Sartorelli, AC | 1 |
Brattain, MG; Casazza, AM; Long, BH; Lorico, A; Wang, L; Wang, RC | 1 |
Bertrand, R; Jenkin, J; Kerrigan, D; Pommier, Y; Sarang, M | 1 |
Adcock, L; Bundy, BN; Muss, HB | 1 |
Bach, F; Dombernowsky, P; Hansen, HH; Sørensen, JB | 1 |
Frankendal, B; Sorbe, B; Wolmesjö, E | 1 |
5 review(s) available for arginine and Adenocarcinoma
Article | Year |
---|---|
Role of Nuclear Factor Erythroid 2-Related Factor 2 (NRF-2) Mediated Antioxidant Response on the Synergistic Antitumor Effect of L-Arginine and 5-Fluro Uracil (5FU) in Breast Adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antioxidants; Arginine; Breast Neoplasms; Fluorouracil; Humans; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species | 2019 |
Consumption of Red/Processed Meat and Colorectal Carcinoma: Possible Mechanisms Underlying the Significant Association.
Topics: Adenocarcinoma; Adenoma; Animals; Arginine; Bone Morphogenetic Proteins; Colorectal Neoplasms; Epigenesis, Genetic; Fatty Acids, Omega-6; Feeding Behavior; Food Handling; Hedgehog Proteins; Heme; Humans; Intestines; Mutagens; Neoplastic Stem Cells; Nitroso Compounds; Receptors, Notch; Red Meat; Risk Factors; Wnt Signaling Pathway | 2016 |
Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Arginine; Asian People; Carcinoma, Squamous Cell; Case-Control Studies; Esophageal Neoplasms; Female; Genetic Variation; Humans; Male; Middle Aged; Polymorphism, Genetic; Proline; Risk Factors; Tumor Suppressor Protein p53; Young Adult | 2010 |
Tumour-associated hormonal products.
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Arginine; Biliary Tract Diseases; Bronchial Neoplasms; Carcinoma; Chorionic Gonadotropin; Colonic Neoplasms; Cushing Syndrome; Erythropoietin; Female; Follicle Stimulating Hormone; Growth Hormone; Gynecomastia; Hormones, Ectopic; Humans; Hypercalcemia; Lactation Disorders; Lung Neoplasms; Luteinizing Hormone; Models, Biological; Neoplasms; Paraganglioma; Paraneoplastic Endocrine Syndromes; Polycythemia; Pregnancy; Prolactin; Thyroid Neoplasms; Vasopressins | 1974 |
The biology and treatment of superficial bladder cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystoscopy; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
8 trial(s) available for arginine and Adenocarcinoma
Article | Year |
---|---|
ADMA mediates gastric cancer cell migration and invasion via Wnt/β-catenin signaling pathway.
Topics: Adenocarcinoma; Arginine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Stomach Neoplasms; Wnt Signaling Pathway; Wound Healing | 2021 |
Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer undergoing irreversible electroporation (IRE).
Topics: Ablation Techniques; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amino Acids, Branched-Chain; Arginine; Dietary Supplements; Electroporation; Enteral Nutrition; Fatty Acids, Omega-3; Female; Glutamine; Humans; Immunomodulation; Male; Middle Aged; Nucleotides; Nutritional Status; Pancreatic Neoplasms; Pilot Projects; Postoperative Complications; Preoperative Care; Treatment Outcome; Weight Loss | 2017 |
L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma.
Topics: Adenocarcinoma; Adenoma; Arginine; Cell Proliferation; Colorectal Neoplasms; Double-Blind Method; Female; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Male; Microtubule-Associated Proteins; Middle Aged; Neoplasm Proteins; Nitric Oxide; Nitric Oxide Synthase; Ornithine Decarboxylase; Proliferating Cell Nuclear Antigen; Survivin | 2007 |
Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Dietary Supplements; Double-Blind Method; Doxorubicin; Drug Synergism; Female; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisone; Radiotherapy, Adjuvant; Vincristine | 1998 |
[VM-26 plus CCNU in the prevention of brain metastasis in lung cancer patients].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Teniposide | 1995 |
Use of VM-26 as a single agent in the treatment of renal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Bone Marrow; Clinical Trials as Topic; Female; Humans; Hypotension; Kidney Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1979 |
Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Drug Evaluation; Humans; Infusions, Parenteral; Leiomyosarcoma; Male; Mitosis; Neoplasm Metastasis; Podophyllotoxin; Prostatic Neoplasms; Teniposide; Teratoma; Testicular Neoplasms; Therapeutic Irrigation; Urinary Bladder Neoplasms | 1975 |
Teniposide (VM-26) in patients with advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Survival Rate; Teniposide; Uterine Neoplasms | 1991 |
110 other study(ies) available for arginine and Adenocarcinoma
Article | Year |
---|---|
Arginine ADP-ribosyltransferase 1 Regulates Glycolysis in Colorectal Cancer via the PI3K/AKT/HIF1α Pathway.
Topics: Adenocarcinoma; ADP Ribose Transferases; Animals; Arginine; Cell Line, Tumor; Colonic Neoplasms; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Phosphatidylinositol 3-Kinases; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins c-akt | 2022 |
Investigation of the Lethal Effect of Purified Arginine Deiminase Purified from Lactobacillus plantarum p5 on Murine Mammary Adenocarcinoma and Vero cell Lines.
Topics: Adenocarcinoma; Animals; Arginine; Breast Neoplasms; Cell Line, Tumor; Chlorocebus aethiops; Hydrolases; Lactobacillus plantarum; Mammary Neoplasms, Animal; Mice; Vero Cells | 2022 |
Neurotensin analogs by fluoroglycosylation at N
Topics: Adenocarcinoma; Animals; Arginine; Humans; Male; Mice; Neurotensin; Pancreatic Neoplasms; Positron-Emission Tomography; Receptors, Neurotensin; Tomography, X-Ray Computed | 2022 |
Developing and Testing Methylated Nano-Structured Dipeptides that Inhibit Src Kinase Activity In Vitro for Anti-Cancer Applications.
Topics: Adenocarcinoma; Arginine; Cell Line, Tumor; Dipeptides; Humans; Peptides; src-Family Kinases; Tryptophan | 2022 |
Thrombolysis for acute pulmonary embolism after major hepatic surgery.
Topics: Acute Disease; Adenocarcinoma; Appendiceal Neoplasms; Arginine; Atrial Fibrillation; Bronchoscopy; Catheters; Colectomy; Computed Tomography Angiography; Diagnosis, Differential; Electric Countershock; Fibrinolytic Agents; Heparin; Hepatectomy; Humans; Infusions, Intravenous; Intubation, Intratracheal; Liver Neoplasms; Lung; Male; Middle Aged; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Troponin I; Ultrasonography; Venous Thrombosis | 2017 |
Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell.
Topics: Acetogenins; Adenocarcinoma; Animals; Arginine; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glycerophospholipids; Humans; Mammary Neoplasms, Animal; Metabolomics; Proline | 2018 |
Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models.
Topics: Adenocarcinoma; Animals; Apoptosis; Arginase; Arginine; Biomarkers, Tumor; Cell Proliferation; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Ornithine; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyethylene Glycols; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
Topics: Adenocarcinoma; Arginine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Codon; DNA; DNA-Binding Proteins; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; India; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prognosis; Risk Factors; Survival Rate; X-ray Repair Cross Complementing Protein 1 | 2013 |
Fatty acid modified octa-arginine for delivery of siRNA.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Arginine; Cell Line, Tumor; Cell-Penetrating Peptides; Cytochalasin D; Dose-Response Relationship, Drug; Endocytosis; Fatty Acids; Hep G2 Cells; Humans; Lung Neoplasms; Nanoparticles; RNA, Small Interfering; Sucrose | 2015 |
A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Topics: A549 Cells; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenocarcinoma of Lung; Arginine; Breast Neoplasms; Carcinoma, Squamous Cell; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Lung Neoplasms; MCF-7 Cells; Methylation; Neoplasm Invasiveness; Neoplasms; Prognosis; Protein-Arginine N-Methyltransferases; Sequence Analysis, RNA; Transcription, Genetic; Transforming Growth Factor beta | 2017 |
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Antihypertensive Agents; Arginine; Benzopyrans; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Size; Dose-Response Relationship, Drug; Drug Combinations; Elasticity; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Ethanolamines; Female; Fulvestrant; Genes, Reporter; Humans; Metoprolol; Nanotechnology; Nebivolol; Nitric Oxide; Nitrites; Tamoxifen; Time Factors; Transfection | 2009 |
p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Arginine; Boston; Carcinoma, Squamous Cell; Cell Differentiation; Cohort Studies; Esophageal Neoplasms; Female; Genotype; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Prognosis; Proline; Prospective Studies; Proto-Oncogene Proteins c-mdm2; Survival Rate; Tumor Suppressor Protein p53; Young Adult | 2009 |
Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Arginine; Cardia; Case-Control Studies; Codon; Cytosine; DNA Repair; DNA-Binding Proteins; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glutamine; Haplotypes; Histidine; Humans; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Smoking; Stomach Neoplasms; Thymine; Tryptophan; X-ray Repair Cross Complementing Protein 1 | 2009 |
Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancer.
Topics: Adenocarcinoma; Animals; Arginine; CD11b Antigen; Cell Proliferation; Disease Progression; Immune Tolerance; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelopoiesis; NG-Nitroarginine Methyl Ester; Piperazines; Prostatic Neoplasms; Purines; Sildenafil Citrate; Sulfones; T-Lymphocytes; Tumor Cells, Cultured | 2011 |
GPRC6A regulates prostate cancer progression.
Topics: Adenocarcinoma; Animals; Arginine; Calcium; Cell Line, Tumor; Cell Proliferation; Chemotaxis; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Disease Progression; Humans; In Vitro Techniques; Male; Mice; Mice, Knockout; Osteocalcin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, G-Protein-Coupled; RNA, Messenger; RNA, Small Interfering | 2012 |
Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells.
Topics: Adenocarcinoma; Apoptosis; Arginine; Carboxypeptidases; Cell Line, Tumor; Cell Survival; Humans; Male; Nitric Oxide; Prolactin; Prostatic Neoplasms; RNA, Small Interfering; Signal Transduction; Testosterone; Up-Regulation | 2012 |
p73 gene mutations in gastric adenocarcinomas.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Arginine; Base Sequence; DNA, Neoplasm; Esophagogastric Junction; Genes, Neoplasm; Glutamine; Humans; Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Stomach Neoplasms | 2003 |
Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Arginine; Cardia; Codon; Genes, p53; Humans; Immunohistochemistry; Middle Aged; Stomach Neoplasms; Tumor Suppressor Protein p53 | 2003 |
PROTEOLYTIC ENZYMES AND THEIR INHIBITORS IN HUMAN GYNECOLOGICAL TUMORS.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aminopeptidases; Arginine; Carcinoma; Carcinoma, Squamous Cell; Cathepsins; Clinical Enzyme Tests; Colorimetry; Cystine; Cysts; Enzyme Inhibitors; Female; Histocytochemistry; Humans; Leucyl Aminopeptidase; Neoplasm Metastasis; Ovarian Neoplasms; Pathology; Peptide Hydrolases; Trypsin; Uterine Neoplasms | 1965 |
Prognostic value of TP53 codon 72 polymorphism in advanced gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Age Distribution; Aged; Aged, 80 and over; Arginine; Codon; DNA, Neoplasm; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Risk Factors; Stomach Neoplasms; Survival Rate | 2004 |
Met proto-oncogene juxtamembrane rare variations in mouse and humans: differential effects of Arg and Cys alleles on mouse lung tumorigenesis.
Topics: Adenocarcinoma; Alleles; Amino Acid Sequence; Animals; Arginine; Carcinoma, Non-Small-Cell Lung; Cell Transformation, Neoplastic; Cysteine; Disease Models, Animal; DNA Mutational Analysis; Genetic Linkage; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Lung Neoplasms; Mice; Mice, Inbred Strains; Molecular Sequence Data; Multifactorial Inheritance; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Receptors, Growth Factor; Receptors, Thrombin; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
The transport of cationic amino acids in human airway cells: expression of system y+L activity and transepithelial delivery of NOS inhibitors.
Topics: Adenocarcinoma; Amino Acid Transport System y+L; Amino Acids; Animals; Arginine; Biological Transport; Cations; Cell Line; Cell Line, Tumor; Cell Membrane Permeability; Culture Media, Conditioned; Epithelial Cells; Gene Expression; Humans; Lung Neoplasms; Lysine; Macrophages; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Respiratory System; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.
Topics: Adenocarcinoma; Animals; Arginase; Arginine; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Humans; Interferon-gamma; Lymphocyte Count; Lymphocytes, Tumor-Infiltrating; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide Synthase; Organ Culture Techniques; Prostatic Neoplasms; T-Lymphocyte Subsets; Tyrosine | 2005 |
Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study.
Topics: Adenocarcinoma; Adult; Aged; Arginine; Case-Control Studies; Confounding Factors, Epidemiologic; Cysteine; DNA Repair; Europe, Eastern; Female; Genotype; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polymorphism, Genetic; Research Design; Risk Assessment; Risk Factors; Selection Bias; Serine; Smoking; Tryptophan | 2005 |
The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population.
Topics: Adenocarcinoma; Adult; Aged; Arginine; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; China; DNA Helicases; DNA Repair; DNA-Binding Proteins; Ethnicity; Female; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Male; Middle Aged; Polymorphism, Genetic; Risk Factors; Sex Factors; Smoking; Transcription Factors; Xeroderma Pigmentosum Group D Protein | 2005 |
L-Arginine modulates CXC chemokines in the human intestinal epithelial cell line HCT-8 by the NO pathway.
Topics: Adenocarcinoma; Arginine; Cell Line, Tumor; Cell Survival; Chemokines, CXC; Humans; Intestinal Mucosa; Nitric Oxide; Nitric Oxide Donors; omega-N-Methylarginine; RNA, Messenger | 2005 |
Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase.
Topics: Adenocarcinoma; Arginine; Breast Neoplasms; Humans; Hydrolases; Lung Neoplasms; Neoplasms; Nitric Oxide; Nitric Oxide Synthase; Polyamines; Protein Biosynthesis; Tumor Cells, Cultured | 2006 |
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Topics: Adenocarcinoma; Arginine; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Polymorphism, Genetic; Proline; Risk Factors; Tumor Suppressor Protein p53 | 2006 |
Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Carcinoma, Squamous Cell; Codon; Cyclin-Dependent Kinase Inhibitor p21; Female; Genetic Variation; Humans; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Proline; Risk Factors; Serine; Smoking; Tumor Suppressor Protein p53 | 2007 |
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Colorectal Neoplasms, Hereditary Nonpolyposis; DNA Mutational Analysis; Exons; Female; Germ-Line Mutation; Humans; Italy; Kidney Neoplasms; Male; Microsatellite Instability; Middle Aged; Molecular Diagnostic Techniques; Mutation, Missense; MutS Homolog 2 Protein; Neoplasms, Multiple Primary; Oligonucleotide Probes; Pedigree; Serine | 2007 |
Effect of an immunonutrient mix on human colorectal adenocarcinoma cell growth and viability.
Topics: Adenocarcinoma; Analysis of Variance; Apoptosis; Arginine; Caco-2 Cells; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Fatty Acids, Omega-3; Flow Cytometry; Glutamine; Growth Inhibitors; Humans; RNA | 2007 |
Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Arginine; Argininosuccinate Synthase; Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Eye Enucleation; Eye Neoplasms; Female; Humans; Hydrolases; Recombinant Proteins; Retinoblastoma | 2007 |
Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.
Topics: Adenocarcinoma; Animals; Antigens, Polyomavirus Transforming; Arginine; Cell Transformation, Neoplastic; Disease Models, Animal; Disease Progression; Female; Genes, p53; Histidine; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Transgenic; Mutation, Missense; Oncogenes; Phenotype; Point Mutation; Tumor Suppressor Protein p53 | 2008 |
Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide.
Topics: Adenocarcinoma; Animals; Arginine; Cell Line; Cell Transformation, Viral; Colonic Neoplasms; Complement Inactivator Proteins; Dansyl Compounds; Humans; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Platelet Aggregation; Rabbits; Simian virus 40 | 1982 |
Free amino acid pools of rodent mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Amino Acids; Animals; Arginine; Cystathionine; Female; gamma-Aminobutyric Acid; Lactation; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasm Transplantation; Pregnancy; Rats; Rats, Inbred Strains | 1982 |
Arginine content in serum protein fractions of mice with mammary adenocarcinoma.
Topics: Adenocarcinoma; Amino Acids; Animals; Arginine; Blood Proteins; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Molecular Weight; Neoplasm Transplantation; Peptides; Protein Binding; Serum Albumin | 1982 |
Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.
Topics: Adenocarcinoma; Animals; Arginine; Cell Line; Colonic Neoplasms; Dansyl Compounds; Humans; Mice; Neoplasms, Experimental; Neoplastic Cells, Circulating; Neuraminidase; Phospholipases A; Phospholipases A2; Platelet Aggregation; Rabbits; Thrombin; Trypsin | 1981 |
Prevention of isoniazid tumorigenicity by antitoxicants of isoniazid in Swiss mice.
Topics: Adenocarcinoma; Ammonia; Animals; Arginine; Folic Acid; Isoniazid; Kidney; Liver; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Protein Biosynthesis; Pyridoxine; Sodium Glutamate | 1980 |
N omega-hydroxy-L-arginine, a reactional intermediate in nitric oxide biosynthesis, induces cytostasis in human and murine tumor cells.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Biological Transport; Cell Division; Cell Line; Cell Survival; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Mammary Neoplasms, Experimental; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase; Tumor Cells, Cultured | 1993 |
Biosynthesis of nitric oxide activates iron regulatory factor in macrophages.
Topics: Aconitate Hydratase; Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Cells, Cultured; Enzyme Induction; Interferon-gamma; Iron-Regulatory Proteins; Kinetics; Leukemia L1210; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mitochondria; Molsidomine; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Recombinant Proteins; RNA-Binding Proteins; Tumor Cells, Cultured | 1993 |
Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Arginine; Base Sequence; Citrulline; Colonic Neoplasms; Gene Expression; Humans; Isoenzymes; Lipopolysaccharides; Molecular Sequence Data; Nitric Oxide; Nitric Oxide Synthase; RNA, Messenger; Tumor Cells, Cultured | 1994 |
Reciprocal modulation of aconitase activity and RNA-binding activity of iron regulatory factor by nitric oxide.
Topics: Aconitate Hydratase; Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Interferon-gamma; Iron-Regulatory Proteins; Leukemia P388; Lipopolysaccharides; Macrophages; Mice; Molsidomine; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Recombinant Proteins; RNA-Binding Proteins; RNA, Messenger; Tumor Cells, Cultured; Vasodilator Agents | 1994 |
Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Female; Mammary Neoplasms, Experimental; Microcirculation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Perfusion; Rats; Rats, Inbred F344; Regional Blood Flow; Venules | 1995 |
Metabolism of L-arginine through polyamine and nitric oxide synthase pathways in proliferative or differentiated human colon carcinoma cells.
Topics: Adenocarcinoma; Arginine; Cell Differentiation; Cell Division; Colonic Neoplasms; Dipeptidyl Peptidase 4; Glutamine; Humans; Nitric Oxide Synthase; Ornithine; Polyamines; Putrescine; Tumor Cells, Cultured | 1995 |
Characterization and growth factor stimulation of L-arginine transport in a human colon cancer cell line.
Topics: Adenocarcinoma; Amino Acids; Arginine; Carrier Proteins; Cell Division; Cell Membrane Permeability; Colonic Neoplasms; Epidermal Growth Factor; Humans; Hydrogen-Ion Concentration; Ion Channel Gating; Nitric Oxide; Radioisotopes; Time Factors; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1995 |
K-ras-2 topographic genotyping of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Alanine; Arginine; Aspartic Acid; Codon; Cysteine; DNA, Neoplasm; Exons; Forecasting; Genes, ras; Genotype; Glycine; Humans; Leucine; Mutation; Pancreas; Pancreatic Neoplasms; Serine; Survival Rate; Valine | 1994 |
Mechanisms of Kupffer cell cytotoxicity in vitro against the syngeneic murine colon adenocarcinoma line MCA26.
Topics: Adenocarcinoma; Animals; Arginine; Colonic Neoplasms; Cytotoxicity, Immunologic; Female; Immune Sera; Interleukin-1; Kupffer Cells; Mice; Mice, Inbred BALB C; Nitric Oxide; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1993 |
Can daily dietary arginine supplement affect the function and subpopulation of lymphocytes in patients with advanced gastric cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Arginine; Female; Humans; Leukocyte Count; Lymphocyte Activation; Lymphocyte Subsets; Lymphocytes; Male; Middle Aged; Stomach Neoplasms | 1993 |
Flavone acetic acid and 5,6-dimethylxanthenone-4-acetic acid: relationship between plasma nitrate elevation and the induction of tumour necrosis.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arginine; Canavanine; Colonic Neoplasms; Flavonoids; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Necrosis; Nitrates; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Xanthenes; Xanthones | 1993 |
NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Antineoplastic Agents; Arginine; Capillary Permeability; Combined Modality Therapy; Female; Immunotherapy; Interleukin-2; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pleural Effusion, Malignant; Pulmonary Edema; Statistics, Nonparametric; Tumor Cells, Cultured | 1996 |
A cohort of supporting metabolic enzymes is coinduced with nitric oxide synthase in human tumor cell lines.
Topics: Adenocarcinoma; Arginine; Argininosuccinate Synthase; Cell Line; Enzyme Induction; GTP Cyclohydrolase; Humans; Interferon-gamma; Interleukin-1; Isoenzymes; Kinetics; Liver; Nitric Oxide Synthase; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Effects of N(g)-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arginine; Capillary Permeability; Cell Division; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Interleukin-12; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pleural Effusion; Pulmonary Edema | 1996 |
Exogenous nitric oxide stimulates mucin secretion from LS174T colonic adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Arginine; Carcinoid Tumor; Cell Survival; Colonic Neoplasms; Epithelial Cells; Epithelium; Humans; Isotope Labeling; Mice; Mice, Inbred BALB C; Mice, Nude; Mucins; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Tumor Cells, Cultured; Vasodilator Agents | 1996 |
Ca(2+)-dependent nitric oxide release in endothelial but not R3230Ac rat mammary adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Arginine; Calcium; Calcium-Transporting ATPases; Cell Line; Endothelium, Vascular; Female; Fibroblasts; Humans; Immunoblotting; Isoenzymes; Mammary Neoplasms, Experimental; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Thapsigargin | 1996 |
Purification and inhibitor screening of human nitric oxide synthase isozymes.
Topics: Adenocarcinoma; Arginine; Brain; Carbon Radioisotopes; Cell Line; Chromatography, Affinity; Chromatography, Gel; Colorectal Neoplasms; Cytokines; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Female; Humans; Indicators and Reagents; Isoenzymes; Kinetics; Neurons; Nitric Oxide Synthase; Placenta; Pregnancy; Radioisotope Dilution Technique | 1996 |
Increased L-arginine transport in a nitric oxide-producing metastatic colon cancer cell line.
Topics: Adenocarcinoma; Arginine; Biological Transport; Cell Division; Cell Membrane; Colonic Neoplasms; Coloring Agents; Dexamethasone; Glucocorticoids; Humans; Hydrogen-Ion Concentration; Kinetics; Lymphatic Metastasis; Nitric Oxide; Sodium; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Up-Regulation | 1996 |
Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Alleles; Amino Acid Sequence; Arginine; Carcinoma; Carcinoma, Small Cell; Codon; Female; Gene Deletion; Gene Frequency; Genes, p53; Genetic Predisposition to Disease; Genotype; Glutathione Transferase; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Polymorphism, Genetic; Proline; Risk Factors; Smoking; Spain | 1996 |
Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor.
Topics: Adenocarcinoma; Amidines; Animals; Arginine; Benzylamines; Colonic Neoplasms; Enzyme Inhibitors; Hematopoietic Stem Cells; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nitrates; Nitric Oxide Synthase; Nitrites; Transplantation, Heterologous | 1997 |
Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
Topics: Adenocarcinoma; Aged; Alleles; Arginine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Codon; Disease Susceptibility; Female; Genes, p53; Genetic Carrier Screening; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Risk Factors; Smoking | 1998 |
The effects of l-arginine on crypt cell hyperproliferation in colorectal cancer.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Adenoma; Animals; Arginine; Carcinogens; Cell Division; Colon; Colonic Neoplasms; Colorectal Neoplasms; Intestinal Mucosa; Male; Mitotic Index; Rats; Rats, Wistar | 1999 |
Determination of endogenous formaldehyde in plants (fruits) bound to L-arginine and its relation to the folate cycle, photosynthesis and apoptosis.
Topics: Adenocarcinoma; Apoptosis; Arginine; Chromatography, High Pressure Liquid; Colonic Neoplasms; Folic Acid; Formaldehyde; Humans; Photosynthesis; Plants; Tumor Cells, Cultured | 1998 |
Polymorphism at codon 72 of p53 is not associated with cervical cancer risk.
Topics: Adenocarcinoma; Alleles; Arginine; Carcinoma in Situ; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Codon; DNA, Neoplasm; Female; Gene Frequency; Homozygote; Humans; Neoplasm Invasiveness; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2000 |
Constitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell lines.
Topics: Adenocarcinoma; Arginine; Colonic Neoplasms; Humans; Neuropeptide Y; Pancreatic Polypeptide; Peptides, Cyclic; Receptors, Neuropeptide Y; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA; Somatostatin; Structure-Activity Relationship; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 2001 |
Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity.
Topics: Adenocarcinoma; Animals; Arginase; Arginine; Biogenic Polyamines; Breast Neoplasms; Cell Division; Coculture Techniques; Cytotoxicity, Immunologic; Humans; Macrophage Activation; Macrophages; Mice; Nitric Oxide; Ornithine; Rats; Transfection; Valine | 2001 |
The role of dynamin and its binding partners in coated pit invagination and scission.
Topics: Adaptor Protein Complex 2; Adaptor Protein Complex alpha Subunits; Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Adenocarcinoma; Amino Acid Sequence; Animals; Arginine; Brain; Carrier Proteins; Cell Line; Cell Membrane; Clathrin; Cloning, Molecular; Coated Pits, Cell-Membrane; Dynamins; Endocytosis; GTP Phosphohydrolases; Humans; Inositol Phosphates; Membrane Proteins; Molecular Sequence Data; Nerve Tissue Proteins; Proline; Rats; Recombinant Fusion Proteins; src Homology Domains; Transfection; Tumor Cells, Cultured | 2001 |
Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.
Topics: Adenocarcinoma; Aged; Alleles; Arginine; Carcinoma, Squamous Cell; Case-Control Studies; Codon; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Glutathione Transferase; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Polymorphism, Genetic; Proline | 2001 |
A study of endocrine and metabolic variables in postmenopausal women with endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Arginine; Estrogens; Female; Glucose; Gonadotropins, Pituitary; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Insulin; Menopause; Middle Aged; Prospective Studies; Receptors, Estrogen; Uterine Neoplasms | 1979 |
Inhibitory effect of L-arginine on growth of rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Adenofibroma; Animals; Arginine; Diet; Female; Mammary Neoplasms, Experimental; Rats | 1975 |
Fluorescent cytochemistry of calid and algid normal and Lucké tumor-bearing kidneys.
Topics: Adenocarcinoma; Animals; Anura; Arginine; Carboxylic Acids; Cell Nucleus; Cytoplasm; Disulfides; DNA, Neoplasm; Fluorescent Dyes; Glycogen; Histocytochemistry; Inclusion Bodies, Viral; Kidney Neoplasms; Kidney Tubules; Lysine; Neoplasm Proteins; Rana pipiens; RNA, Neoplasm; Seasons; Sulfhydryl Compounds | 1975 |
Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Colonic Neoplasms; Male; Melanoma, Experimental; Methylene Blue; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostheses and Implants; Regional Blood Flow | 1992 |
Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Blotting, Western; Citrulline; Electron Spin Resonance Spectroscopy; Enzyme Induction; Free Radicals; Kinetics; Mammary Neoplasms, Experimental; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Nitroarginine; Ribonucleotide Reductases; Tumor Cells, Cultured; Tyrosine | 1992 |
Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alanine; Amino Acids; Arginine; Breast Neoplasms; Carcinoma, Squamous Cell; Discriminant Analysis; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Male; Middle Aged; Sex Factors; Threonine | 1992 |
Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Arginine; Colorectal Neoplasms; Epoprostenol; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Aggregation; Purinones; Tumor Cells, Cultured; Vasodilator Agents | 1991 |
Depletion of dietary arginine inhibits growth of metastatic tumor.
Topics: Adenocarcinoma; Animals; Arginine; Colonic Neoplasms; Diet; Disease Models, Animal; In Vitro Techniques; Liver Neoplasms; Mice; Mice, Inbred BALB C; Tumor Cells, Cultured | 1991 |
Independence of the pattern of early cytokine release from autoregulation by nitric oxide.
Topics: Adenocarcinoma; Animals; Arginine; Culture Media; Cytokines; Female; Homeostasis; Interferon-gamma; L Cells; Lipopolysaccharides; Macrophage Activation; Macrophages; Male; Mammary Neoplasms, Experimental; Mice; Nitric Oxide; Nitrites; omega-N-Methylarginine; Peritoneal Cavity; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |
Activated macrophage conditioned medium: identification of the soluble factors inducing cytotoxicity and the L-arginine dependent effector mechanism.
Topics: Aconitate Hydratase; Adenocarcinoma; Animals; Arginine; Blotting, Western; Chromatography, Gel; Culture Media; DNA; Dose-Response Relationship, Drug; Female; Immunity, Cellular; Interferon-gamma; Lipopolysaccharides; Macrophage Activation; Macrophages; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitrites; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |
Insulin secretion and action in patients with pancreatic cancer.
Topics: Adenocarcinoma; Adult; Arginine; Blood Glucose; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Pancreatic Neoplasms | 1991 |
High-performance liquid chromatographic analysis of the unusual pathway of oxidation of L-arginine to citrulline and nitric oxide in mammalian cells.
Topics: Adenocarcinoma; Animals; Arginine; Cell Line; Chromatography, High Pressure Liquid; Citrulline; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitric Oxide; Oxidation-Reduction | 1991 |
Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Arginine; Cell Line; Dactinomycin; DNA Replication; Interferon-gamma; Interleukin-1; Kinetics; Lipopolysaccharides; Mammary Neoplasms, Experimental; Mice; Nitrites; omega-N-Methylarginine; Recombinant Proteins; Ribonucleotide Reductases; Thymidine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |
Production of an arginine-derived relaxing factor induced by IFN-gamma plus endotoxin in murine adenocarcinoma EMT 6 cells.
Topics: Adenocarcinoma; Aminoquinolines; Animals; Aorta, Thoracic; Arginine; Cell Division; Cell Line; Endotoxins; In Vitro Techniques; Interferon-gamma; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Recombinant Proteins; SRS-A; Vasodilation | 1990 |
A novel leupeptin-sensitive serine endopeptidase present in normal and malignant rat mammary tissues.
Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Arginine; Benzoylarginine Nitroanilide; Chromatography; Female; Hydrogen-Ion Concentration; Hydrolysis; Leupeptins; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Molecular Sequence Data; Oligopeptides; Rats; Rats, Inbred Strains; Serine Endopeptidases; Substrate Specificity | 1990 |
Intermittent hepatic dearterialization induces glucose intolerance: an experimental study in the rat.
Topics: Adenocarcinoma; Animals; Arginine; Blood Glucose; Glucagon; Glucose; Homeostasis; Insulin; Insulin Secretion; Ischemia; Liver; Liver Neoplasms; Male; Neoplasm Transplantation; Rats; Rats, Inbred WF | 1990 |
Antiproliferative activity of gamma-interferon combined with lipopolysaccharide on murine adenocarcinoma: dependence on an L-arginine metabolism with production of nitrite and citrulline.
Topics: Adenocarcinoma; Animals; Arginine; Cell Division; Citrulline; Interferon-gamma; Kinetics; Lipopolysaccharides; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitrites; Recombinant Proteins; Tumor Cells, Cultured | 1989 |
Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinic Acid; Blood Platelets; Breast Neoplasms; Creatinine; Dipyridamole; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Plasmapheresis; Sulfinpyrazone; Tablets, Enteric-Coated; Time Factors | 1986 |
The L-arginine dependent effector mechanism is induced in murine adenocarcinoma cells by culture supernatant from cytotoxic activated macrophages.
Topics: Adenocarcinoma; Arginase; Arginine; Cell Division; Cell Line; Macrophage Activation; Macrophages | 1988 |
In vitro and in vivo immunomodulatory activity of an N-9 arginyl hypoxanthine derivative (PCF-39).
Topics: Adenocarcinoma; Animals; Arginine; Cell Cycle; Female; Hypoxanthines; Killer Cells, Natural; Leukocyte Count; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Spleen | 1987 |
Responses of plasma ACTH, GH, LH and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome.
Topics: Adenocarcinoma; Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Arginine; Carbon Isotopes; Cushing Syndrome; Growth Hormone; Humans; Hydroxycorticosteroids; Hypoglycemia; Insulin; Luteinizing Hormone; Lysine; Pituitary Irradiation; Stimulation, Chemical; Vasopressins | 1972 |
Quantitative effects of nutritional essential amino acid deficiency upon immune responses to tumors in mice.
Topics: Adenocarcinoma; Amino Acids; Animals; Antibodies, Neoplasm; Antigen-Antibody Complex; Arginine; Cells, Cultured; Cysteine; Cytotoxicity Tests, Immunologic; Deficiency Diseases; Diet; Histidine; Immunity, Cellular; Isoleucine; Lysine; Male; Mammary Neoplasms, Experimental; Methionine; Mice; Mice, Inbred C3H; Mice, Inbred CBA; Phenylalanine; Threonine; Time Factors; Tryptophan; Tyrosine; Valine | 1973 |
Studies of glucagon secretion in pancreatectomized patients.
Topics: Adenocarcinoma; Adult; Arginine; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Humans; Injections, Intravenous; Insulin; Male; Methods; Middle Aged; Neoplasm Metastasis; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Radioimmunoassay | 1974 |
Patterns of amino-acid inhibition of alkaline phosphatases as an aid in cancer diagnosis.
Topics: Adenocarcinoma; Alanine; Alkaline Phosphatase; Amino Acids; Animals; Arginine; Colonic Neoplasms; Female; Humans; In Vitro Techniques; Isoenzymes; Lung Neoplasms; Mammary Neoplasms, Experimental; Neoplasms; Phenylalanine; Rats; Valine | 1971 |
Amino acid incorporation patterns during the cell cycle of synchronized human tumor cells.
Topics: Adenocarcinoma; Amino Acids; Arginine; Autoradiography; Cell Division; Cell Nucleus; Culture Techniques; Cytoplasm; Glycine; Humans; Leucine; Lysine; Microscopy, Phase-Contrast; Thymidine; Tritium; Tryptophan | 1966 |
miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Carrier Proteins; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Organoplatinum Compounds; Oxaliplatin; Teniposide | 2011 |
Soft agar colony formation assay for in vitro chemotherapy sensitivity testing of human renal cell carcinoma: Mayo Clinic experience.
Topics: Adenocarcinoma; Agar; Antineoplastic Agents; Bleomycin; Cells, Cultured; Dactinomycin; Drug Evaluation; Humans; Hydroxyurea; Kidney Neoplasms; Mitoguazone; Nephrectomy; Teniposide | 1984 |
Combination chemotherapy for metastatic brain tumors.
Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Nitrosourea Compounds; Podophyllotoxin; Prognosis; Teniposide; Tomography, X-Ray Computed | 1981 |
Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents.
Topics: Adenocarcinoma; Animals; Cell Survival; Colonic Neoplasms; Etoposide; Humans; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Podophyllotoxin; Skin Ulcer; Solvents; Teniposide; Tumor Stem Cell Assay | 1983 |
Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship.
Topics: Adenocarcinoma; Cell Line; Cell Survival; DNA; DNA Repair; Etoposide; Humans; Kinetics; Lung Neoplasms; Podophyllotoxin; Structure-Activity Relationship; Teniposide | 1984 |
An adherent cell model to study different stages of apoptosis.
Topics: Adenocarcinoma; Apoptosis; Cell Adhesion; Cell Size; Colonic Neoplasms; DNA, Neoplasm; Humans; Teniposide; Tumor Cells, Cultured | 1995 |
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Teniposide; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
Biomodulation by hyperthermia of topoisomerase II-targeting drugs in human colorectal cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Cycle; Colorectal Neoplasms; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Hot Temperature; Humans; Neoplasm Proteins; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine | 1995 |
A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell line.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Colonic Neoplasms; Cyclophosphamide; Dipyridamole; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Idarubicin; Mitoxantrone; Neoplasm Proteins; Teniposide; Tumor Cells, Cultured; Verapamil; Vinblastine | 1999 |
VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Thrombocytopenia | 1978 |
Recruitment-chemoradiotherapy with VM 26 (epipodophyllotoxin) for induction treatment of malignant brain tumours.
Topics: Adenocarcinoma; Animals; Brain Neoplasms; Cell Line; Fibrosarcoma; Glioma; Humans; Mitosis; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Radiotherapy Dosage; Rats; Teniposide; Vincristine | 1979 |
Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
Topics: Adenocarcinoma; Antineoplastic Agents; Blotting, Northern; Blotting, Southern; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Line; Cell Survival; Cisplatin; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Phenotype; Restriction Mapping; RNA, Neoplasm; Teniposide | 1992 |
Potentiation by novobiocin of the cytotoxic activity of etoposide (VP-16) and teniposide (VM-26).
Topics: Adenocarcinoma; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; DNA; DNA Topoisomerases, Type II; Drug Synergism; Etoposide; Humans; Leukemia; Lung Neoplasms; Novobiocin; RNA; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1992 |
Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cell Line; Colonic Neoplasms; DNA; DNA Damage; DNA Probes; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Humans; Immunoblotting; Lung Neoplasms; Membrane Glycoproteins; Molecular Sequence Data; Neoplasm Proteins; Porfiromycin; RNA; Teniposide | 1991 |
Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression.
Topics: Adenocarcinoma; Colonic Neoplasms; DNA Damage; DNA Repair; DNA, Neoplasm; Etoposide; Gene Amplification; Genes, myc; Humans; Leukemia, Promyelocytic, Acute; Teniposide; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1991 |
Phase II study of teniposide in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Remission Induction; Teniposide; Thrombocytopenia | 1991 |
VM-26-vincristine-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Teniposide; Uterine Neoplasms; Vincristine | 1989 |
DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Topics: Adenocarcinoma; Adenosine Triphosphate; Carcinoma, Small Cell; Cell Division; Cell Nucleus; Cells, Cultured; DNA; DNA, Single-Stranded; Drug Resistance; Etoposide; Humans; Intercalating Agents; Lung Neoplasms; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1986 |
Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide.
Topics: Adenocarcinoma; Aminoacridines; Amsacrine; Cells, Cultured; DNA; DNA Repair; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Teniposide | 1985 |